| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
David L. Lewis last filed a Form 4 in January 2016, as Chief Scientific Officer at ARWR. David L. Lewis's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
David L. Lewis has 3 Form 4 filings on record from January 2015 to January 2016, all as Chief Scientific Officer at Arrowhead Pharmaceuticals (ARWR), 2015–2016.
The 4 reported transactions were 2 option or other derivative awards, 1 option exercise and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $120K.
The only open-market sale was 15,000 shares of ARWR at an average $8.01 on January 5, 2015, about $120K.
Shares as reported in the last Form 4 for each company; the most recent is from January 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2015 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 15,000 | $8.01 | $120,103.50 | - |